Mankind Pharma IPO refers to the initial public offering (IPO) of Mankind Pharma, which is set to open for subscription on April 25 and close on April 27. The IPO consists of a pure offer for sale of up to 40.06 million shares by its existing shareholders and promoters. The anchor bidding will start on April 24, and the equity shares will be credited on May 8. The stock will be listed on exchanges on May 9. Mankind Pharma is the fourth largest pharmaceutical company in India based on domestic sales and the second largest based on sales volume for the financial year 2022.
Mankind Pharma is a pharmaceutical company based in India. It was founded in 1986 by Ramesh Juneja and has since become the fourth largest pharmaceutical company in India based on domestic sales and the second largest based on sales volume for the financial year 2022. The company produces and markets a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as a range of consumer healthcare products. Its popular products include Manforce Condoms, Prega News pregnancy test kits, and Unwanted-72 emergency contraceptives. The company is supported by private equity firms Chrys Capital and Capital International, and it has one of the largest networks of medical representatives in the Indian pharmaceutical market.
Mankind Pharma has several popular brands in its portfolio, including Manforce Condoms, Prega News, Unwanted-72, Gas-O-Fast, Health OK, AcneStar, Adiction, Healmont, Mom's Care, Man Matters.